Â鶹ӳ»­

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data from researchers at Â鶹ӳ»­ MD Anderson Cancer Center. 

Five-year results from the Phase II trial, published today in JAMA Oncology, revealed that breast cancer still had not returned in...